Diets · Metabolic & Cardiometabolic
high dietary omega-6:omega-3 ratio causes chronic inflammation and cardiometabolic disease
In plain terms: Is a high ratio of omega-6 to omega-3 fats bad for your heart and inflammation?
Part of: 🔍 seed oils
Mainstream evidence does not support the ratio as a useful risk marker: higher omega-6/linoleic-acid biomarkers track LOWER heart disease and mortality, and controlled trials show no rise in inflammation, so the ratio hypothesis leans against the harm thesis.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
The ratio is not supported as a risk marker. Raising omega-6 intake, which worsens the ratio, did not raise inflammatory markers in randomised work, higher dietary linoleic acid tracks 15 percent fewer coronary events across thirteen cohorts in 310,602 people, and pooled individual-level biomarkers from 30 cohorts associate linoleic acid with lower cardiovascular and total mortality.
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U 2012 · Am J Clin Nutr | RCT | contradicts | high | Raising n-6 PUFA (worsening ratio) did not increase inflammatory markers in humans, undercutting the ratio-inflammation mechanism. |
| Marventano S, Kolacz P, Castellano S, Galvano F, Buscemi S, Mistretta A, Grosso G 2015 · Int J Food Sci Nutr | observational | mixed | moderate | Review finds omega-3 generally beneficial but the few studies using the n-6:n-3 RATIO give contrasting results; ratio not a robust predictor. |
| Ferro CJ, Thomas MR, Khattak S, Chanouzas D, Townend JN 2026 · Clin Kidney J | observational | tested-null | low | Narrative review, not evidence: 'In this review, we outline the pleiotropic actions of omega-3 polyunsaturated fatty acids'; 'We discuss the PISCES trial ... (1.6 g EPA + 0.8 g DHA daily) in 1228 haemodialysis patients'. No omega-6:omega-3 ratio measured. Review — zero weight. |
| Powers CD, Sternberg MR, Mineva EM, Clifton CC, Leachman JR, Wambogo E, Pfeiffer CM 2026 · Curr Dev Nutr | observational | tested-null | moderate | NHANES cross-sectional data (n=7213) show 54% of the US population has an undesirably low Omega-3 Index (RBC EPA+DHA), which is strongly correlated with sudden cardiac death risk; the paper frames risk purely via absolute erythrocyte omega-3 levels, not a rati |
| Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM 2010 · Br J Nutr | meta-analysis | mixed | moderate | Meta-analysis found n-6-specific (not mixed n-3/n-6) PUFA diets did not reduce and may raise CHD risk, implicating absolute n-3, not the ratio per se. |
| Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, Willett WC, Hu FB 2014 · Circulation | meta-analysis | contradicts | high | Meta-analysis of 13 cohorts (310,602 people): higher dietary linoleic acid linked to 15% lower CHD events and 21% lower CHD death, dose-responsive. |
| Marklund M, Wu JHY, Imamura F, Del Gobbo LC, Fretts A, de Goede J, Shi P, Tintle N, Wennberg M, Aslibekyan S, Chen TA, de Oliveira Otto MC, Hirakawa Y, Eriksen HH, Kröger J, Laguzzi F, Lankinen M, Murphy RA, Prem K, Samieri C, Virtanen J, Wood AC, Wong K, Yang WS, Zhou X, Baylin A, Boer JMA, Brouwer IA, Campos H, Chaves PHM, Chien KL, de Faire U, Djoussé L, Eiriksdottir G, El-Abbadi N, Forouhi NG, Michael Gaziano J, Geleijnse JM, Gigante B, Giles G, Guallar E, Gudnason V, Harris T, Harris WS, Helmer C, Hellenius ML, Hodge A, Hu FB, Jacques PF, Jansson JH, Kalsbeek A, Khaw KT, Koh WP, Laakso M, Leander K, Lin HJ, Lind L, Luben R, Luo J, McKnight B, Mursu J, Ninomiya T, Overvad K, Psaty BM, Rimm E, Schulze MB, Siscovick D, Skjelbo Nielsen M, Smith AV, Steffen BT, Steffen L, Sun Q, Sundström J, Tsai MY, Tunstall-Pedoe H, Uusitupa MIJ, van Dam RM, Veenstra J, Monique Verschuren WM, Wareham N, Willett W, Woodward M, Yuan JM, Micha R, Lemaitre RN, Mozaffarian D, Risérus U, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE) 2019 · Circulation | observational | contradicts | high | Individual-level pooled 30-cohort biomarker analysis: higher linoleic acid associated with lower CVD and total mortality, not higher. |
| Hamley S 2017 · Nutr J | meta-analysis | contradicts | moderate | Meta-analysis of diet-heart RCTs found replacing SFA with n-6 PUFA gave no clear CHD benefit once confounders removed, undercutting simple ratio arguments. |
| Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F 2009 · Circulation | observational | contradicts | high | AHA science advisory: omega-6 PUFA intake of 5-10% energy lowers CHD risk; explicitly rejects the omega-6:omega-3 ratio as a useful concept. |
| Messina M, Shearer G, Petersen K 2021 · Nutrition | observational | contradicts | moderate | Review: soybean oil (largest US omega-6 source) lowers cholesterol and CHD risk with no effect on inflammation or oxidation markers; health agencies reject the ratio. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.